The transcription levels of FOXD2-AS1, CDC45, CDC20, CDK1, and CCNB1 were quantified in blood from 100 Primary AML- non M3 patients and 50 G-CSF-mobilized healthy blood samples. This evidence concerns the gene CCNB1 and acute myeloid leukemia.